Community perceptions of mass screening and treatment for malaria in Siaya County, western Kenya

Kathryn Shuford, Florence Were, Norbert Awino, Aaron Samuels, Peter Ouma, Simon Kariuki, Meghna Desai, Denise Roth Allen, Kathryn Shuford, Florence Were, Norbert Awino, Aaron Samuels, Peter Ouma, Simon Kariuki, Meghna Desai, Denise Roth Allen

Abstract

Background: Intermittent mass screening and treatment (iMSaT) is currently being evaluated as a possible additional tool for malaria control and prevention in western Kenya. The literature identifying success and/or barriers to drug trial compliance and acceptability on malaria treatment and control interventions is considerable, especially as it relates to specific target groups, such as school-aged children and pregnant women, but there is a lack of such studies for mass screening and treatment and mass drug administration in the general population.

Methods: A qualitative study was conducted to explore community perceptions of the iMSaT intervention, and specifically of testing and treatment in the absence of symptoms, before and after implementation in order to identify aspects of iMSaT that should be improved in future rounds. Two rounds of qualitative data collection were completed in six randomly selected study communities: a total of 36 focus group discussions (FGDs) with men, women, and opinion leaders, and 12 individual or small group interviews with community health workers. All interviews were conducted in the local dialect Dholuo, digitally recorded, and transcribed into English. English transcripts were imported into the qualitative software programme NVivo8 for content analysis.

Results: There were mixed opinions of the intervention. In the pre-implementation round, respondents were generally positive and willing to participate in the upcoming study. However, there were concerns about testing in the absence of symptoms including fear of covert HIV testing and issues around blood sampling. There were fewer concerns about treatment, mostly because of the simpler dosing regimen of the study drug (dihydroartemisinin-piperaquine) compared to the current first-line treatment (artemether-lumefantrine). After the first implementation round, there was a clear shift in perceptions with less common concerns overall, although some of the same issues around testing and general misconceptions about research remained.

Conclusions: Although iMSaT was generally accepted throughout the community, proper sensitization activities-and arguably, a more long-term approach to community engagement-are necessary for dispelling fears, clarifying misconceptions, and educating communities on the consequences of asymptomatic malaria.

References

    1. WHO. World Malaria Report 2015. Geneva: World Health Organization. 2015.
    1. Snow RW, Marsh K. Malaria in Africa: progress and prospects in the decade since the Abuja declaration. Lancet. 2010;376:137–139. doi: 10.1016/S0140-6736(10)60577-6.
    1. Silumbe K, Chiyende E, Finn TP, Desmond M, Puta C, Hamainza B, et al. A qualitative study of perceptions of a mass test and treat campaign in Southern Zambia and potential barriers to effectiveness. Malar J. 2015;14:171. doi: 10.1186/s12936-015-0686-3.
    1. Okello G, Ndegwa SN, Halliday KE, Hanson K, Brooker SJ, Jones C. Local perceptions of intermittent screening and treatment for malaria in school children on the south coast of Kenya. Malar J. 2012;11:185. doi: 10.1186/1475-2875-11-185.
    1. Atkinson JA, Bobogare A, Fitzgerald L, Boaz L, Appleyard B, Toaliu H, et al. A qualitative study on the acceptability and preference of three types of long-lasting insecticide-treated bed nets in Solomon Islands: implications for malaria elimination. Malar J. 2009;8:119. doi: 10.1186/1475-2875-8-119.
    1. Gysels M, Pell C, Mathanga DP, Adongo P, Odhiambo F, Gosling R, et al. Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings. Malar J. 2009;8:191. doi: 10.1186/1475-2875-8-191.
    1. Pool R, Munguambe K, Macete E, Aide P, Juma G, Alonso P, et al. Community response to intermittent preventive treatment delivered to infants (IPTi) through the EPI system in Manhica Mozambique. Trop Med Int Health. 2006;11:1670–1678. doi: 10.1111/j.1365-3156.2006.01725.x.
    1. Pell C, Straus L, Phuanukoonnon S, Lupiwa S, Mueller I, Senn N, et al. Community response to intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea. Malar J. 2010;9:369. doi: 10.1186/1475-2875-9-369.
    1. Pool R, Mushi A, Schellenberg J, Mrisho M, Alonso P, Montgomery C, et al. The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania. Malar J. 2008;7:213. doi: 10.1186/1475-2875-7-213.
    1. Smith LA, Jones C, Adjei RO, Antwi GD, Afrah NA, Greenwood B, et al. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: user acceptability. Malar J. 2010;9:18. doi: 10.1186/1475-2875-9-18.
    1. Ansah EK, Reynolds J, Akanpigbiam S, Whitty C, Chandler C. Even if the test result is negative, they should be able to tell us what is wrong with us”: a qualitative study of patient expectations of rapid diagnostic tests for malaria. Malar J. 2013;12:258. doi: 10.1186/1475-2875-12-258.
    1. Mukanga D, Tibenderana JK, Kiguli J, Pariyo GW, Waiswa P, Bajunirwe F, et al. Community acceptability of use of rapid diagnostic tests for malaria by community health workers in Uganda. Malar J. 2010;9:203. doi: 10.1186/1475-2875-9-203.
    1. Munguambe K, Pool R, Montgomery C, Bavo C, Nhacolo A, Fiosse L, et al. What drives community adherence to indoor residual spraying (IRS) against malaria in Manhiça district, rural Mozambique: a qualitative study. Malar J. 2011;10:344. doi: 10.1186/1475-2875-10-344.
    1. Tine RCK, Ndiaye P, Ndour CT, Faye B, Ndiaye JL, Sylla K, et al. Acceptability by community health workers in Senegal of combining community case management of malaria and seasonal malaria chemoprevention. Malar J. 2013;12:467. doi: 10.1186/1475-2875-12-467.
    1. Omedo MO, Matey EJ, Awiti A, Ogutu M, Alaii J, Karanja DMS, et al. Community health workers’ experiences and perspectives on mass drug administration for schistosomiasis control in Western Kenya: the SCORE project. Am J Trop Med Hyg. 2012;87:1065–1072. doi: 10.4269/ajtmh.2012.12-0435.
    1. Caldwell B. Mark Nichter: Global Health: Why cultural perceptions, social representations, and biopolitics matter. J Pop Research. 2009;26:203–205. doi: 10.1007/s12546-009-9013-6.
    1. Geissler PW. ‘Kachinja are coming!’: encounters around medical research work in a Kenyan village. Africa. 2005;75:173–202. doi: 10.3366/afr.2005.75.2.173.
    1. Lindblade KA, Eisele TP, Gimnig JE, Alaii JA, Odhiambo F, ter Kuile FO, et al. Sustainability of reductions in malaria transmission and infant mortality in Western Kenya with use of insecticide-treated bednets. JAMA. 2004;291:2571–2580. doi: 10.1001/jama.291.21.2571.
    1. USAID. Malaria Fact Sheet—Kenya. 2013.
    1. Kenya NACCo. Kenya AIDS Response Progress Report. 2014.
    1. Peeters Grietens K, Ribera JM, Erhart A, Hoibak S, Ravinetto RM, Gryseels C, et al. Doctors and vampires in sub-Saharan Africa: ethical challenges in clinical trial research. Am J Trop Med Hyg. 2014;91:213–215. doi: 10.4269/ajtmh.13-0630.
    1. Geissler PW, Pool R. Editorial: popular concerns about medical research projects in sub-Saharan Africa—a critical voice in debates about medical research ethics. Trop Med Int Health. 2006;11:975–982. doi: 10.1111/j.1365-3156.2006.01682.x.
    1. Brinkman I. Book review: White, L. Speaking with vampires: rumor and history in colonial Africa. Berkeley: University of California Press, 2000. Africa Today 2001. 48:162–4.
    1. Molyneux CS, Peshu N, Marsh K. Trust and informed consent: insights from community members on the Kenyan coast. Soc Sci Med. 2005;61:1463–1473. doi: 10.1016/j.socscimed.2004.11.073.
    1. Parker M, Allen T, Hastings J. Resisting control of neglected tropical diseases: dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west Uganda. J Biosoc Sci. 2008;40:161–181. doi: 10.1017/S0021932007002301.
    1. Parker M, Allen T. Will mass drug administration eliminate lymphatic filariasis? Evidence from northern coastal Tanzania. J Biosoc Sci. 2013;45:517–545. doi: 10.1017/S0021932012000466.
    1. Dial NJ, Ceesay SJ, Gosling RD, D’Alessandro U, Baltzell KA. A qualitative study to assess community barriers to malaria mass drug administration trials in the Gambia. Malar J. 2014;13:47. doi: 10.1186/1475-2875-13-47.
    1. Marsh V, Kamuya D, Rowa Y, Gikonyo C, Molyneux S. Beginning community engagement at a busy biomedical research programme: experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya. Soc Sci Med. 2008;67:721–733. doi: 10.1016/j.socscimed.2008.02.007.
    1. Marsh VM, Kamuya DM, Mlamba AM, Williams TN, Molyneux SS. Experiences with community engagement and informed consent in a genetic cohort study of severe childhood diseases in Kenya. BMC Med Ethics. 2010;11:13. doi: 10.1186/1472-6939-11-13.
    1. Okello G, Jones C, Bonareri M, Ndegwa SN, Mcharo C, Kengo J, et al. Challenges for consent and community engagement in the conduct of cluster randomized trial among school children in low income settings: experiences from Kenya. Trials. 2013;14:142. doi: 10.1186/1745-6215-14-142.
    1. Angwenyi V, Kamuya D, Mwachiro D, Kalama B, Marsh V, Njuguna P, et al. Complex realities: community engagement for a paediatric randomized controlled malaria vaccine trial in Kilifi, Kenya. Trials. 2014;15:65. doi: 10.1186/1745-6215-15-65.

Source: PubMed

3
Tilaa